K2LTS Telomerase Inhibitor

Ginsenoside 35mg(17.5%)

For early stage cancer patients

This product is suitable for patients with early-stage cancer.
Inhibits telomerase activity, thus preventing the proliferation and growth of tumor cells;
Stabilizing gene mutations and stabilizing chromosomes;

Side Effects：Avoid concurrent use with other drugs.

Consult a doctor before use.

This product may cause mild gastrointestinal discomfort, occasional allergicreactions.

This product contains Ginsenosides and EGCG extract. Do not use if you areallergic to these ingredients.

The concurrent use of drugs or increased exposure to this product may lead to clinically significant adverse reactions.

The concurrent use of drugs significantly reduces the concentration of this product, resulting in decrease of the therapeutic effect of the concurrent drugs used.

Stop use and ask a doctor if irritation or rash occurs

Stop use and ask a doctor if irritation or rash occurs

Please keep this product away from children. If the child accidentally ingests this product, please seek medical help immediately.

Twist the cap and administrate directly. Twice a day. Do not exceed the recommended dosage.

Storage Method：The product should be stored in a cool, dry, and dark environment with a temperature range of 16°C to 27°C(60-80℉), and humidity not exceeding 50%.

EGCG 55mg, Sulforaphane 40mg, Ashitaba leaf extract 30mg, Ergothioneine 20mg, Cordycepin 10mg, Selenium 5mg.

Other ingredients

Sodium benzoate 3mg, Borneol 2mg.

1